Lyra Therapeutics (LYRA) Total Liabilities (2019 - 2025)
Quarterly Total Liabilities fell 14.48% to $46.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.8 million through Dec 2025, down 14.48% year-over-year, with the annual reading at $46.8 million for FY2025, 14.48% down from the prior year.
Lyra Therapeutics' Total Liabilities history spans 7 years, with the latest figure at $46.8 million for Q4 2025.
- Total Liabilities came in at $46.8 million for Q4 2025, down from $48.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $64.0 million in Q1 2024 to a low of $5.4 million in Q1 2021.
- The 5-year median for Total Liabilities is $32.8 million (2022), against an average of $37.6 million.
- Year-over-year, Total Liabilities fell 26.99% in 2021 and then soared 348.9% in 2022.
- Lyra Therapeutics' Total Liabilities stood at $20.6 million in 2021, then soared by 42.15% to $29.2 million in 2022, then surged by 82.04% to $53.2 million in 2023, then grew by 2.96% to $54.8 million in 2024, then fell by 14.48% to $46.8 million in 2025.
- Per Business Quant, the three most recent readings for LYRA's Total Liabilities are $46.8 million (Q4 2025), $48.0 million (Q3 2025), and $51.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 9.45 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 10.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Lyra Therapeutics | - | - | - | 46.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.83 Mn |
| Sep 30, 2025 | 48.04 Mn |
| Jun 30, 2025 | 50.95 Mn |
| Mar 31, 2025 | 52.44 Mn |
| Dec 31, 2024 | 54.75 Mn |
| Sep 30, 2024 | 58.14 Mn |
| Jun 30, 2024 | 63.61 Mn |
| Mar 31, 2024 | 64.02 Mn |
| Dec 31, 2023 | 53.18 Mn |
| Sep 30, 2023 | 36.34 Mn |
| Jun 30, 2023 | 27.10 Mn |
| Mar 31, 2023 | 27.78 Mn |
| Dec 31, 2022 | 29.21 Mn |
| Sep 30, 2022 | 26.24 Mn |
| Jun 30, 2022 | 23.79 Mn |
| Mar 31, 2022 | 24.09 Mn |
| Dec 31, 2021 | 20.55 Mn |
| Sep 30, 2021 | 20.57 Mn |
| Jun 30, 2021 | 18.83 Mn |
| Mar 31, 2021 | 5.37 Mn |
| Dec 31, 2020 | 6.34 Mn |
| Sep 30, 2020 | 6.42 Mn |
| Jun 30, 2020 | 5.90 Mn |
| Mar 31, 2020 | 7.35 Mn |
| Dec 31, 2019 | 7.64 Mn |
| Sep 30, 2019 | 119.01 Mn |
| Jun 30, 2019 | 114.84 Mn |
| Mar 31, 2019 | 110.69 Mn |